According to Laboratorios Farmaceuticos Rovi's latest financial reports the company's current EPS (TTM) is 3,46ย โฌ. In 2022 the company made an earnings per share (EPS) of 3,69ย โฌ an increase over its 2021 EPS that were of 2,95ย โฌ.